Specifications - DSM Biologics Biopharmaceutical Manufacturing Facility Expansion, Montreal, Canada

Key Data
Order year	2002
Project type	Expansion
Location	Metro, Montreal, Quebec, Canada
Estimated Investment	$460m
Completion	Phase 1 – 2004/2005; 2006 plant mothballed for foreseeable future
Key Players
Sponsor	DSM Biologics
Lead engineer / designer	SNC-Lavalin Pharma (SLP)
Building constructor	JE Verreault
Bioreactor design and construction	Biolafitte (Pierre Guérin)
Control systems	SNC-Lavalin pharma (SLP)
Financing	SGF (Societe Generale de Financement du Quebec) - $91m
	Province of Quebec - $33m
Output Chemicals
Type	Recombinant Proteins, Monoclonal Antibodies
Featured Suppliers
Applikon Biotechnology - Bioreactor Systems
Senn Chemicals - Amino Acid Derivatives, Un-Natural Amino Acids, Peptides, Resins, Carbohydrates And Reagents For The Pharmaceutical, Nutraceutical + Cosmetic Industry